UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial

Journal of clinical oncology, 2015-05, Vol.33 (13), p.1438-1445

2015

Volltextzugriff (PDF)

Biomarker-Driven Personalized Immunoprevention: Toward More Efficient Clinical Trials?

Cancer prevention research (Philadelphia, Pa.), 2024-09, Vol.17 (9), p.399-400

2024

Volltextzugriff (PDF)

Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial

Journal of clinical oncology, 2015-05, Vol.33 (13), p.1446-1452

2015

Volltextzugriff (PDF)

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A

Journal of clinical oncology, 2022-07, Vol.40 (21), p.2295-2307

2022

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients

Cancer treatment reviews, 2013-12, Vol.39 (8), p.839-850

2013

Volltextzugriff (PDF)

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

The Journal of clinical investigation, 2010-04, Vol.120 (4), p.1298-1309

2010

Volltextzugriff (PDF)

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

Expert opinion on biological therapy, 2011-12, Vol.11 (12), p.1663-1668

2011

Volltextzugriff (PDF)

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer

Pharmaceuticals (Basel, Switzerland), 2023-02, Vol.16 (2), p.233

2023

Volltextzugriff (PDF)

Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies

Clinical lung cancer, 2021-09, Vol.22 (5), p.449-460

2021

Volltextzugriff (PDF)

The beginning of the perioperative immunotherapy era in early-stage non-small cell lung cancer

Translational lung cancer research, 2023-11, Vol.12 (11), p.2359-2365

2023

Volltextzugriff (PDF)

Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

Frontiers in cell and developmental biology, 2023-04, Vol.11, p.1170444

2023

Volltextzugriff (PDF)

Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines

Cancer prevention research (Philadelphia, Pa.), 2023-10, Vol.16 (10), p.549-560

2023

Volltextzugriff (PDF)

Family Caregiver Depressive Symptom and Grief Outcomes From the ENABLE III Randomized Controlled Trial

Journal of pain and symptom management, 2016-09, Vol.52 (3), p.378-385

2016

Volltextzugriff (PDF)

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth‐Hitchcock Medical Center

The oncologist (Dayton, Ohio), 2015-09, Vol.20 (9), p.1011-1018

2015

Volltextzugriff (PDF)

Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors

Lung cancer management, 2019-10, Vol.8 (2)

2019

Volltextzugriff (PDF)

Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)

Clinical cancer research, 2023-09, Vol.29 (18), p.3641-3649

2023

Volltextzugriff (PDF)

The Role of a Palliative Care Intervention in Moderating the Relationship Between Depression and Survival Among Individuals With Advanced Cancer

Health psychology, 2017-12, Vol.36 (12), p.1140-1146

2017

Volltextzugriff (PDF)

Uncovering Growth-Suppressive MicroRNAs in Lung Cancer

Clinical cancer research, 2009-02, Vol.15 (4), p.1177-1183

2009

Volltextzugriff (PDF)

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

Journal for immunotherapy of cancer, 2020-10, Vol.8 (2), p.e000847

2020

Volltextzugriff (PDF)

Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)

Journal of thoracic oncology, 2024-08

2024

Volltextzugriff (PDF)

A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer

Clinical lung cancer, 2021-11, Vol.22 (6), p.531-540

2021

Volltextzugriff (PDF)

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.32-12, Article 32

2018

Volltextzugriff (PDF)

Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images

Translational oncology, 2022-10, Vol.24, p.101494-101494, Article 101494

2022

Volltextzugriff (PDF)

Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience

JCO oncology practice, 2021-07, Vol.17 (7), p.OP2000937-374

2021

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Englisch
(160)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Life Sciences & Biomedicine
(86)
Humans
(64)
Oncology
(60)
Male
(33)
Biological And Medical Sciences
(29)
Female
(27)
Medical Sciences
(27)
Animals
(20)
Lung Cancer
(19)
Middle Aged
(19)
Tumors
(19)
Aged
(17)
Lung Neoplasms - Drug Therapy
(14)
Cancer
(13)
Lung Neoplasms - Genetics
(13)
Pharmacology. Drug Treatments
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(12)
Chemotherapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial

Biomarker-Driven Personalized Immunoprevention: Toward More Efficient Clinical Trials?

Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer

Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies

The beginning of the perioperative immunotherapy era in early-stage non-small cell lung cancer

Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines

Family Caregiver Depressive Symptom and Grief Outcomes From the ENABLE III Randomized Controlled Trial

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth‐Hitchcock Medical Center

Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors

Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

The Role of a Palliative Care Intervention in Moderating the Relationship Between Depression and Survival Among Individuals With Advanced Cancer

Uncovering Growth-Suppressive MicroRNAs in Lung Cancer

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)

A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images

Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience

Suchergebnisse filtern